Publikationen, an denen er mitarbeitet Ginés Luengo Gil (17)

2023

  1. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2022

  1. Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

    Biomedicines, Vol. 10, Núm. 1

  2. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

    Cancers, Vol. 14, Núm. 10

2021

  1. Anti-tumor functions of prelatent antithrombin on glioblastoma multiforme cells

    Biomedicines, Vol. 9, Núm. 5

  2. N-glycosylation as a tool to study antithrombin secretion, conformation, and function

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-12

  3. Qualitative and quantitative comparison of plasma exosomes from neonates and adults

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-21

2019

  1. Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells

    Biochimie, Vol. 165, pp. 245-249

  2. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy

    Cellular Oncology, Vol. 42, Núm. 5, pp. 627-644

2018

  1. Angiogenic role of miR-20a in breast cancer

    PLoS ONE, Vol. 13, Núm. 4

  2. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia

    British Journal of Haematology, Vol. 182, Núm. 3, pp. 373-383

2017

  1. Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens

    Scientific Reports, Vol. 7

2016

  1. Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase

    Scientific Reports, Vol. 6

2015

  1. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis

    Breast Cancer Research and Treatment, Vol. 151, Núm. 3, pp. 577-587

2014

  1. Regulation of coagulation factor XI expression by MicroRNAs in the human liver

    PLoS ONE, Vol. 9, Núm. 11

  2. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 90, Núm. 3, pp. 595-602

2013

  1. Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms

    Oncologist, Vol. 18, Núm. 4, pp. 446-453

  2. Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: Clonal evolution and hierarchy revealed by next-generation sequencing

    Journal of Hematology and Oncology, Vol. 6, Núm. 1